Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Thorax”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT02355431
What this trial is testing

Itacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations

Who this might be right for
Solid Tumors and Hematologic MalignancyNSCLC (Non-small Cell Lung Carcinoma)
Incyte Corporation
Large-scale testing (Phase 3)Study completedNCT01763645
What this trial is testing

A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Biocad 353
Not applicableUnknownNCT05803746
What this trial is testing

PD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid Tumor

Who this might be right for
Lung CancerColorectal Cancer
Peking University Cancer Hospital & Institute 20
Early research (Phase 1)Study completedNCT02603003
What this trial is testing

The"Fuzheng" Therapy of TCM to Improve the Survival Quality of Early-stage NSCLC by Intervening the CTCs

Who this might be right for
Non-small Cell Lung Cancer(NSCLC)
Shanghai University of Traditional Chinese Medicine 218
Large-scale testing (Phase 3)Study completedNCT02604342
What this trial is testing

Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and Crizotinib

Who this might be right for
Non-small Cell Lung Cancer
Hoffmann-La Roche 119
Large-scale testing (Phase 3)Active Not RecruitingNCT05224141
What this trial is testing

Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)

Who this might be right for
Small Cell Lung Carcinoma
Merck Sharp & Dohme LLC 460
Early research (Phase 1)Active Not RecruitingNCT03025256
What this trial is testing

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

Who this might be right for
Acral Lentiginous MelanomaCentral Nervous System MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8+7 more
M.D. Anderson Cancer Center 75
Not applicableLooking for participantsNCT03199651
What this trial is testing

Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Cigarette SmokerCurrent SmokerLung Adenocarcinoma+2 more
Ohio State University Comprehensive Cancer Center 3,584
Not applicableNot Yet RecruitingNCT06694129
What this trial is testing

Real-world Observational Study of Targeted Therapy in Patients With Advanced ROS1-positive NSCLC

Who this might be right for
Non-Small Cell Lung CancerROS1 Gene RearrangementResistance+1 more
National Cancer Center, China 40
Testing effectiveness (Phase 2)Study completedNCT00294762
What this trial is testing

Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
OSI Pharmaceuticals 143
Testing effectiveness (Phase 2)Study completedNCT01876446
What this trial is testing

Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Recurrent Small Cell Lung Carcinoma
Roswell Park Cancer Institute 38
Not applicableNot Yet RecruitingNCT06993896
What this trial is testing

Physical Activity During Chemo- and/or Immunotherapy for Lung Cancer

Who this might be right for
Lung Cancer (NSCLC)
University Hospital Schleswig-Holstein 38
Early research (Phase 1)Ended earlyNCT03580694
What this trial is testing

Study of REGN4659 in Combination With Cemiplimab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Regeneron Pharmaceuticals 17
Testing effectiveness (Phase 2)Looking for participantsNCT06830694
What this trial is testing

Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) With Etoposide, Carboplatin and Atezolizumab in Transformed Small Cell Lung Cancer Patients From Adenocarcinoma After EGFR TKI Treatment

Who this might be right for
Small Cell Carcinoma of Lung
Sehhoon Park 50
Testing effectiveness (Phase 2)UnknownNCT02407366
What this trial is testing

Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
People's Hospital of Guangxi Zhuang Autonomous Region 80
Early research (Phase 1)Study completedNCT03629756
What this trial is testing

Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies

Who this might be right for
Non-small Cell Lung CancerSquamous Cell Carcinoma of the Head and NeckBreast Cancer+9 more
Arcus Biosciences, Inc. 48
Very early researchUnknownNCT02817945
What this trial is testing

Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging

Who this might be right for
Lung CancerNeuroendocrine Neoplasm
Peking Union Medical College Hospital 100
Early research (Phase 1)Study completedNCT00016237
What this trial is testing

Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Bladder CancerKidney CancerLung Cancer
EMD Serono
Not applicableActive Not RecruitingNCT06942845
What this trial is testing

Exploration of Risk Factors for Postoperative Cerebral Infarction in Lung Cancer Patients: a Retrospective Single-centre Study

Who this might be right for
Lung Cancer, Non-Small CellPostoperative Cerebral Infarction
Xinghua Cheng 300
Not applicableStudy completedNCT01776372
What this trial is testing

Comparison of Pleural Drainage Systems on Reducing Pleural Effusion Formation Following Lung Resection

Who this might be right for
Lung NeoplasmsPleural Effusion
McMaster University 103
Next Page